World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Australia
2023
Award Badge
Medicine
Australia
2023

D-Index & Metrics

Biology and Biochemistry

D-Index
83
Citations
39599
World Ranking
3426
National Ranking
78

Medicine

D-Index
89
Citations
42823
World Ranking
12452
National Ranking
403

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in Australia Leader Award
  • 2023 - Research.com Medicine in Australia Leader Award
  • 2022 - Research.com Biology and Biochemistry in Australia Leader Award
  • 2013 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 1994 - Fellow of American Physical Society (APS) Citation For playing a leading role in enactment of energy efficiency laws and regulations in the United States

Overview

David Goldstein is affiliated with the University of New South Wales in Australia and has an extensive research portfolio primarily within the field of Medicine. Their work addresses several subfields, including Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Public Health, Environmental and Occupational Health, and Genetics.

Their research focuses intensely on topics related to cancer, especially pancreatic and hepatic oncology. Other significant areas of study include cancer treatment and pharmacology, cancer genomics and diagnostics, chemotherapy-related skin toxicity, gastric cancer management and outcomes, cancer cells and metastasis, and multiple myeloma research and treatments.

Frequent publication venues for this scientist include the following journals:

  • Journal of Clinical Oncology
  • Supportive Care in Cancer
  • Annals of Oncology
  • Radiotherapy and Oncology
  • Pancreatology

Notable recent papers authored or co-authored by David Goldstein include:

  • "Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group" (2023, Journal of Clinical Oncology)
  • "Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition" (2021, Cancer Research)
  • "Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial" (2022, Journal of Clinical Oncology)
  • "Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy" (2021, JAMA Network Open)
  • "Targeting HGF/c-MET Axis in Pancreatic Cancer" (2020, International Journal of Molecular Sciences)

Collaboration is a significant aspect of their work, with frequent co-authors including:

  • Susanna B. Park (31 joint publications)
  • Tiffany Li (18 joint publications)
  • Hannah C. Timmins (16 joint publications)
  • Terry Trinh (16 joint publications)
  • Mandy L. Ballinger (16 joint publications)

David Goldstein has received recognition from professional organizations, including being named a Fellow of the American Association for the Advancement of Science (AAAS) in 2013. Additionally, they were awarded Fellowship of the American Physical Society (APS) in 1994, with a citation acknowledging their role in energy efficiency legislation and regulations in the United States.

Best Publications

  • Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

    Daniel D. Von Hoff;Thomas Ervin;Francis P. Arena;E. Gabriela Chiorean

  • Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

    John P. Neoptolemos;Deborah D. Stocken;Claudio Bassi;Paula Ghaneh

  • Chemotherapy-induced peripheral neurotoxicity: a critical analysis.

    Susanna B. Park;David Goldstein;Arun V. Krishnan;Cindy S-Y Lin

  • (Open Access) Supercapacitor and supercapattery as emerging electrochemical energy stores

    Unknown

  • Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells.

    M. V. Apte;S. Park;P. A. Phillips;N. Santucci

  • nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

    David Goldstein;Robert Hassan El-Maraghi;Pascal Hammel;Volker Heinemann

  • Cancer patient preferences for communication of prognosis in the metastatic setting.

    Rebecca G. Hagerty;Phyllis N. Butow;Peter A. Ellis;Elizabeth A. Lobb

  • Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells

    Alain Vonlaufen;Swapna Joshi;Changfa Qu;Phoebe A. Phillips

  • Binary temporal upconversion codes of Mn2+-activated nanoparticles for multilevel anti-counterfeiting

    Unknown

  • Efficient image super-resolution using pixel attention

    Unknown

  • Real-Time Energy Storage Management for Renewable Integration in Microgrids: An Off-line Optimization Approach

    Unknown

  • Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study

    Juan W. Valle;Daniel Palmer;Richard Jackson;Trevor Cox

  • Role of Pancreatic Stellate Cells in Pancreatic Cancer Metastasis

    Zhihong Xu;Alain Vonlaufen;Phoebe A. Phillips;Eva Fiala-Beer

  • Fertility- and Menopause-Related Information Needs of Younger Women With a Diagnosis of Early Breast Cancer

    Belinda Thewes;B. Meiser;A. Taylor;K. A. Phillips

  • Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study

    Jeanne Tie;Joshua D Cohen;Yuxuan Wang;Lu Li

  • Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial

    William Greenhalf;Paula Ghaneh;John P. Neoptolemos;Daniel H. Palmer

  • Environmental Epidemiology, Volume 1: Public Health and Hazardous Wastes

    Unknown

  • Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer

    Desmond Yip;Christos Karapetis;Andrew Strickland;Christopher B Steer

  • QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart�…

    Unknown

  • Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer.

    James F. Bishop;Joanna Dewar;Guy C. Toner;Jennifer Smith

Frequent Co-Authors

Slavé Petrovski
Slavé Petrovski AstraZeneca (United Kingdom)
Joshua A. Frieman
Joshua A. Frieman University of Chicago
Erin L. Heinzen
Erin L. Heinzen University of North Carolina at Chapel Hill
Peter Nugent
Peter Nugent Lawrence Berkeley National Laboratory
Ryan J. Foley
Ryan J. Foley University of California, Santa Cruz
Mark Sullivan
Mark Sullivan University of Southampton
Kevin V. Shianna
Kevin V. Shianna Duke University
H. M. Spinka
H. M. Spinka Argonne National Laboratory
Dongliang Ge
Dongliang Ge Apostle Diagnostics

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a degree in Biology or Biochemistry opens doors to a range of advanced online programs and diverse healthcare careers. Many students choose to further their education by pursuing specialized graduate degrees that build upon their foundational science knowledge.

For those interested in healthcare administration, cahme accredited mha programs offer the flexibility to earn a master’s degree and qualify for leadership roles in hospital and health systems management. If clinical practice is your passion but you prefer a flexible, non-traditional setting, online dnp programs may be a great fit, especially for nurses looking to advance without in-person clinicals.

Ambitious learners aiming for research or executive roles might consider a phd in healthcare management to develop expertise in health policy, leadership, and academic teaching. Meanwhile, science graduates intrigued by the pharmaceutical field can look into pharmd online programs to become licensed pharmacists.

Choosing the right online degree can empower you to build a meaningful career that blends scientific knowledge with a variety of rewarding professional paths in healthcare.

Best Scientists Citing David Goldstein

Trending Scientists

Recently Published Articles